Publication | Open Access
The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models
117
Citations
36
References
2021
Year
m276-SL-PBD has significant antitumor activity across a broad panel of pediatric solid tumor PDX models.
| Year | Citations | |
|---|---|---|
Page 1
Page 1